Cancer Chemotherapy and Pharmacology

, Volume 59, Issue 1, pp 149–150

Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma

Letter to the Editor

DOI: 10.1007/s00280-006-0243-4

Cite this article as:
Porta, C., Mutti, L. & Tassi, G. Cancer Chemother Pharmacol (2007) 59: 149. doi:10.1007/s00280-006-0243-4

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Camillo Porta
    • 1
  • Luciano Mutti
    • 2
  • Gianfranco Tassi
    • 3
  1. 1.Medical OncologyI.R.C.C.S. San Matteo University HospitalPaviaItaly
  2. 2.Local Health Authority 11PiedmontItaly
  3. 3.PneumologyCivic HospitalBresciaItaly